AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $8.46M invested in Akari Therapeutics in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$825K
2
+$143K
3
+$74K
4
Deutsche Bank
Deutsche Bank
Germany
+$68K
5
Renaissance Technologies
Renaissance Technologies
New York
+$68K

Top Sellers

1
-$43K
2
-$34.1K
3
-$22.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.12M
2
$1.62M
3
$1.24M
4
$143K
5
$77K
6
$74K
7
$68K
8
$68K
9
$27K
10
$14K
11
$4K
12
$4K
13
–